Core Points - The company has undergone a governance structure adjustment, including the cancellation of the supervisory board and the election of an employee director [1][9] - Non-independent director Li Heng has resigned from the board due to governance changes and personal work plans, effective immediately upon submission of his resignation [2][3] - Jin Yumei has been elected as the employee director, serving until the end of the current board's term [4] - Following Li Heng's resignation, the company has elected Jin Yumei to the Board's Compensation and Assessment Committee to fill the vacancy [5][11] Group 1 - The company held its first extraordinary shareholders' meeting on September 17, 2025, where the governance structure changes were approved [1][9] - Li Heng's resignation will not reduce the board's membership below the legal minimum [2] - Jin Yumei's election as employee director was conducted democratically by the employee representative assembly [4] Group 2 - The board meeting on September 18, 2025, confirmed the election of Jin Yumei to the Compensation and Assessment Committee, ensuring compliance with legal requirements [5][11] - The board meeting was attended by all seven directors, meeting the necessary quorum for decision-making [9][10] - The board approved a motion to waive the five-day notice requirement for the meeting due to the urgency of the situation [10][11]
健之佳医药连锁集团股份有限公司关于公司非独立董事辞任、选举职工董事及选举职工董事为董事会薪酬与考核委员会委员的公告